Decline depth
-41.2%
From rolling 252-day high of $59.83, 129d ago.
Past the 40% Red List threshold.
Red List
PAHCPhibro Animal Health Corporatio
Healthcare · Drug Manufacturers - Specialty & Generic · small-cap ($1.5B)
-41.2%
from rolling 252-day high of $59.83 set 2026-04-13 · 129d ago
Current
$35.18
Decline depth
-41.2%
Decline σ
4.9σ
TFC
0/5 bearish
Rolling 252-day high
Up day
Down day
Last 90 trading days · data from Alpaca
Since it joined the list
$PAHC landed on the list 2026-05-11, down 39.5% from its 52-week high that day — now down -41.2%.
Roughly where it joined — no recovery, no further break. It bottomed 52.5% below that high along the way.
Decline from the 52-week high as it stood on 2026-05-11 (fixed anchor) → today. Split-adjusted, Alpaca. Observed history, not a forecast.
Structural break signals
PAHC qualifies for the Red List on decline depth.
Time-frame continuity
0/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3.
Decline sigma
4.9σ
Drop from local high over the last 20 bars, expressed in units of the stock's typical daily volatility (1.76% per day).
Past the ≥4σ Watch threshold.
The structural read
What price action says about PAHC.
PAHC qualifies for the Red List on decline depth — down -41.2% from its rolling 252-day high. Past the 40% threshold, the deepest tier in the taxonomy.
Cross-confirmation: decline sigma also reads 4.9σ over 20 bars.
Upstream TFC read: weak alignment, current phase weekly. Last bar types — daily 2D (red), weekly 2U (green), monthly 1 (red).
Earnings on file: 2026-05-06. Tiering is unaffected by earnings dates — listings reflect price structure only.
Questions about PAHC
What people ask.
Why is PAHC on Broken Stocks?
PAHC qualifies for the Red List on decline depth. It is down -41.2% from its rolling 252-day high of $59.83, set on 2026-04-13 — 129d ago.
Is PAHC a falling knife?
Not by the strict technical definition. PAHC is down -41.2% from its 52-week high, but that high was set 129d ago — more than 120 days. A falling knife is usually a recent breakdown from a fresh high, not an established multi-quarter downtrend. PAHC is still on the Red List for decline depth, but the freshness component of a falling knife is missing.
Is PAHC a buy?
Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.
Where is PAHC trading inside its 52-week range?
At $35.18, PAHC sits 27.8% of the way from its 52-week low ($25.58) to its 52-week high ($60.08). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.
How fast has PAHC been declining?
The current 41.2% decline accrued over 129d, which annualizes to roughly -116.6% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.
How does PAHC compare to its sector?
There are 143 other Healthcare tickers on Broken Stocks: 69 Red, 35 Amber, 39 Watch, with 50 showing recovering structural signals. Median sector decline is -36.1% — PAHC's decline is deeper than the sector median.
Does PAHC's earnings date affect its tier?
No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-05-06) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.